Literature DB >> 3907556

The chemotherapy of rodent malaria, XXXIX. Ultrastructural changes following treatment with artemisinine of Plasmodium berghei infection in mice, with observations of the localization of [3H]-dihydroartemisinine in P. falciparum in vitro.

D S Ellis, Z L Li, H M Gu, W Peters, B L Robinson, G Tovey, D C Warhurst.   

Abstract

Ultrastructural changes were followed in Plasmodium berghei after the treatment of the mouse host with a single 10 mg kg-1 dose of artemisinine (qinghaosu). After 30 minutes, changes in the limiting and other membranes of the parasite were seen, together with alterations in ribosomal organization and endoplasmic reticulum. No changes were noted in digestive vacuoles or pigment, but nuclear membrane blebbing developed after one hour and segregation of the nucleoplasm after three hours. Further degenerative changes with disorganization and death occurred from eight hours onwards. The morphological changes in ribosomes and endoplasmic reticulum correlate in time with the depression in protein synthesis observed in P. falciparum in vitro. Similarly, the onset of nucleoplasmic segregation correlates with the development of nucleic acid synthesis inhibition. Tritiated reduced drug was shown to be localized in parasite membranes, indicating that changes in membrane integrity might precede the early depression of protein synthesis. Membrane association of artemisinine may be related to its amphipathic characteristics and similarity in some respects to a sterol.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3907556

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  18 in total

1.  In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum.

Authors:  S Gupta; M M Thapar; W H Wernsdorfer; A Björkman
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Decreased sensitivity of artesunate and chloroquine of Plasmodium falciparum infecting hemoglobin H and/or hemoglobin constant spring erythrocytes.

Authors:  Y Yuthavong; P Butthep; A Bunyaratvej; S Fucharoen
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

3.  Eosin B as a novel antimalarial agent for drug-resistant Plasmodium falciparum.

Authors:  Kristen M Massimine; Michael T McIntosh; Lanxuan T Doan; Chloé E Atreya; Stephan Gromer; Worachart Sirawaraporn; David A Elliott; Keith A Joiner; R Heiner Schirmer; Karen S Anderson
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

4.  Ultrastructural and real-time microscopic changes in P. falciparum-infected red blood cells following treatment with antimalarial drugs.

Authors:  Navakanit Sachanonta; Kesinee Chotivanich; Urai Chaisri; Gareth D H Turner; David J P Ferguson; Nicholas P J Day; Emsri Pongponratn
Journal:  Ultrastruct Pathol       Date:  2011-10       Impact factor: 1.094

Review 5.  Artemisia annua L.: a source of novel antimalarial drugs.

Authors:  H J Woerdenbag; C B Lugt; N Pras
Journal:  Pharm Weekbl Sci       Date:  1990-10-19

6.  Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum.

Authors:  N Kumar; H Zheng
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

7.  Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation.

Authors:  Juan Wang; Liying Huang; Jian Li; Qiangwang Fan; Yicheng Long; Ying Li; Bing Zhou
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

8.  The efficacy of inhibitors involved in spermidine metabolism in Plasmodium falciparum, Anopheles stephensi and Trypanosoma evansi.

Authors:  E Moritz; S Seidensticker; A Gottwald; W Maier; A Hoerauf; J T Njuguna; A Kaiser
Journal:  Parasitol Res       Date:  2004-07-29       Impact factor: 2.289

Review 9.  Antimalarial drugs. An update.

Authors:  D C Warhurst
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

Review 10.  Artemisinins: their growing importance in medicine.

Authors:  Sanjeev Krishna; Leyla Bustamante; Richard K Haynes; Henry M Staines
Journal:  Trends Pharmacol Sci       Date:  2008-08-25       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.